These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 955495)

  • 1. Lithocholate metabolism during chenotherapy for gallstone dissolution. 1. Serum levels of sulphated and unsulphated lithocholates.
    Allan RN; Thistle JL; Hofmann AF; Carter JA; Yu PY
    Gut; 1976 Jun; 17(6):405-12. PubMed ID: 955495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithocholate metabolism during chemotherapy for gallstone dissolution. 2. Absorption and sulphation.
    Allan RN; Thistle JL; Hofmann AF
    Gut; 1976 Jun; 17(6):413-9. PubMed ID: 955496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chenotherapy for gallstone dissolution. II. Induced changes in bile composition and gallstone response.
    Hofmann AF; Thistle JL; Klein PD; Szczepanik PA; Yu PY
    JAMA; 1978 Mar; 239(12):1138-44. PubMed ID: 628065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lack of relationship between hepatotoxicity and lithocholic-acid sulfation in biliary bile acids during chenodiol therapy in the National Cooperative Gallstone Study.
    Fisher RL; Hofmann AF; Converse JL; Rossi SS; Lan SP
    Hepatology; 1991 Sep; 14(3):454-63. PubMed ID: 1874490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of primary bile acid ingestion on bile acid metabolism and biliary lipid secretion in gallstone patients.
    LaRusso NF; Hoffman NE; Hofmann AF; Northfield TC; Thistle JL
    Gastroenterology; 1975 Dec; 69(6):1301-14. PubMed ID: 1193329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings: Lithocholate kinetics in patients ingesting chenodeoxycholic (chenic) acid for gall stone dissolution.
    Allan R; Hofmann AF
    Gut; 1976 May; 17(5):394. PubMed ID: 1278751
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of primary bile acid feeding on cholesterol metabolism and hepatic function in the rhesus monkey.
    Webster KH; Lancaster MC; Hofmann AF; Wease DF; Baggenstoss AH
    Mayo Clin Proc; 1975 Mar; 50(3):134-8. PubMed ID: 1117759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked increase in serum levels of liver enzymes in patients receiving chenic acid and phenobarbital for gallstone dissolution.
    Menghini G; Pallotta B
    Digestion; 1976; 14(2):163-9. PubMed ID: 950079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of varying doses of chenodeoxycholic acid on bile lipid and biliary bile acid composition in gallstone patients: a dose-response study.
    Thistle JL; Hofmann AF; Yu PY; Ott B
    Am J Dig Dis; 1977 Jan; 22(1):1-6. PubMed ID: 835542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic versus physiologic cholestasis: elevated serum concentration of a secondary bile acid in the presence of hepatobiliary disease.
    Balistreri WF; Suchy FJ; Farrell MK; Heubi JE
    J Pediatr; 1981 Mar; 98(3):399-402. PubMed ID: 7205448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased sulfation of lithocholate in patients with cholesterol gallstones during chenodeoxycholate treatment.
    Stiehl A; Raedsch R; Kommerell B
    Digestion; 1975; 12(2):105-10. PubMed ID: 1158064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of the bile acid composition of bile from serum bile acid analysis during gallstone dissolution therapy.
    Whiting MJ; Watts JM
    Gastroenterology; 1980 Feb; 78(2):220-5. PubMed ID: 7350043
    [No Abstract]   [Full Text] [Related]  

  • 13. Portal vein bile acids in patients with severe inflammatory bowel disease.
    Holzbach RT; Marsh ME; Freedman MR; Fazio VW; Lavery I; Jagelman DA
    Gut; 1980 May; 21(5):428-35. PubMed ID: 7429307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular species of biliary phosphatidylcholines in gallstone patients: the influence of treatment with cholic acid and chenodeoxycholic acid.
    Ahlberg J; Curstedt T; Einarsson K; Sjövall J
    J Lipid Res; 1981 Mar; 22(3):404-9. PubMed ID: 7240965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bile acid feeding on cholesterol metabolism in gallstone patients.
    Hoffman NE; Hofmann AF; Thistle JL
    Mayo Clin Proc; 1974 Apr; 49(4):236-9. PubMed ID: 4817832
    [No Abstract]   [Full Text] [Related]  

  • 16. Radioimmunoassay of sulfated lithocholates.
    Cowen AE; Korman MG; Hofmann AF; Turcotte J; Carter JA
    J Lipid Res; 1977 Nov; 18(6):698-703. PubMed ID: 925515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semiquantitative measurement of lithocholic acid compounds in bile from patients with gallstones, before and during treatment with chenodeoxycholic acid.
    Arnfred T; Pedersen L
    Scand J Gastroenterol; 1976; 11(5):497-504. PubMed ID: 959764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
    Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
    J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The goose that laid the golden bile: gallstone dissolution in man with chenodeoxycholic acid.
    Dowling RH
    Ir J Med Sci; 1974 Jul; 0(0):suppl:115-27. PubMed ID: 4212419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.